{"id":482461,"title":"Notice: Tablet Scoring of Subsequent-entry Pharmaceutical Products - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T19:11:10.387000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/notice-tablet-scoring-subsequent-entry-pharmaceutical-products.html?wbdisable=true","snippet":"Notice: Tablet Scoring of Subsequent-entry Pharmaceutical Products March 28, 2017 Our file number: 17-103376-453 Pursuant to Part C, Division 8 of the Food and Drug Regulations (FDR) and of Division 1 of the FDR, this Notice is to inform sponsors of Health Canada's position with…","rawSnapshotUrl":"/api/snapshots/raw/482461","browseUrl":"https://replay.healtharchive.ca/job-6/20260106191110/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/notice-tablet-scoring-subsequent-entry-pharmaceutical-products.html?wbdisable=true#ha_snapshot=482461","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}